This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies and to set your preferences.

Continue
Integrity in our business practices

To maintain trust in our relationships with company stakeholders—patients, customers, shareholders, suppliers and other business partners, and members of the civil society—in which Sanofi operates

Interacting with  the scientific  community
Interacting with the scientific community
Sanofi is committed to acting with the highest standards of integrity and honesty when interacting with the scientific community.
Interacting with  the scientific  community

Interacting with the scientific community is legitimate and essential in ensuring that patients and customers have access to the products they need and that they use Sanofi products correctly for their optimal benefit. These interactions also enable us to obtain feedback and advice about our products. Medicines in research and development, as well in clinical practices, greatly benefit from these interactions. Sanofi also supports medical education, which provides a forum for scientific experts to share their clinical experiences and to learn continuously. Sanofi is committed to acting with the highest standards of integrity and honesty when interacting with the scientific community.

Sanofi interacts with the medical and scientific community in many ways, including:

  • Supporting their medical education by providing fair and balanced information about our products and their appropriate use.
  • Organizing medical or scientific meetings or events, or contributing to scientific and educational meetings organized by third parties.
  • Entering into compensation-for-service arrangements with external experts to perform a meaningful service or activity in medical or scientific-related domains for legitimate needs, such as conducting studies, participating in scientific meetings, and providing consulting services.

Engaging an expert for services must not constitute an inducement to prescribe, purchase, supply, sell, administer, or recommend formulary placement of any Sanofi product or service. We select experts using objective criteria based on the defined need not on the expert’s past or expected future use or recommendation of Sanofi products. Sanofi must be reasonable in reflecting the fair market value of the service when determining compensation of experts for services.